ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/07/25
ANI Pharmaceuticals Reports Record Third Quarter 2025 Financial Results and Raises 2025 GuidanceGlobeNewsWire • 11/07/25
ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating EstimatesSeeking Alpha • 10/28/25
ANI Pharmaceuticals to Report Q3 Earnings: Is a Beat in the Cards?Zacks Investment Research • 10/27/25
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 10/27/25
ANI Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 7, 2025, at 8:30 a.m. ETGlobeNewsWire • 10/24/25
Will This Drug Stock Explode After Earnings As It Did Last Quarter?Investors Business Daily • 10/22/25
ANI Pharmaceuticals Announces NEW DAY Clinical Trial Results to be Presented in Late-Breaking Oral Presentation at the American Academy of Ophthalmology 2025 MeetingGlobeNewsWire • 10/16/25
ANI Pharmaceuticals, Inc. (ANIP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 09/08/25
ANI Pharmaceuticals (ANIP) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 08/28/25
ANI Pharmaceuticals, Inc. (ANIP) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 08/22/25
ANI (ANIP) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 08/11/25
ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass EstimatesZacks Investment Research • 08/08/25
ANI Pharmaceuticals Reports Record Second Quarter 2025 Financial Results and Raises 2025 GuidanceGlobeNewsWire • 08/08/25
ANI Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 8, 2025, at 8:30 a.m. ETGlobeNewsWire • 08/01/25
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 ReleaseZacks Investment Research • 07/29/25
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)GlobeNewsWire • 07/23/25
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8thGlobeNewsWire • 07/02/25
ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare ConferenceGlobeNewsWire • 05/27/25
ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout FlaresGlobeNewsWire • 05/22/25
ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQGlobeNewsWire • 05/12/25